Carl L Gordon's Net Worth

$18.4 Thousand

Who is Carl L Gordon?

Carl L Gordon does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., ArriVent Biopharma, Inc., COMPLETE GENOMICS INC, Turning Point Therapeutics, Inc., AMARIN CORP PLC\UK, Keros Therapeutics, Inc., Intellia Therapeutics, Inc., Theseus Pharmaceuticals, Inc., Alector, Inc., Kinnate Biopharma Inc., SpringWorks Therapeutics, Inc., ACADIA PHARMACEUTICALS INC, Pacira Pharmaceuticals, Inc., BIOCRYST PHARMACEUTICALS INC, ARMO BioSciences, Inc., Prevail Therapeutics Inc., Gemini Therapeutics, Inc. /DE, BiomX Inc., SELECTA BIOSCIENCES INC, Terns Pharmaceuticals, Inc., Oric Pharmaceuticals, Inc., Compass Therapeutics, Inc., Arsanis, Inc., and ACCELERON PHARMA INC.

SEC CIK

Carl L Gordon's CIK is 0001282930

Past Insider Trading and Trends

2023 was Carl L Gordon's most active year for acquiring shares with 12 total transactions. Carl L Gordon's most active month to acquire stocks was the month of May. 2024 was Carl L Gordon's most active year for disposing of shares, totalling 8 transactions. Carl L Gordon's most active month to dispose stocks was the month of July. 2006 saw Carl L Gordon paying a total of $183,900.00 for 15,000 shares, this is the most they've acquired in one year. In 2018 Carl L Gordon cashed out on 18,000 shares for a total of $180,540.00, their largest year based on trade value.